ArticleFrontiers in cardiovascular medicine2026
Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study.
Weihua Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.